Clinical Trial Update: To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial evaluating ursodeoxycholic acid for prevention of gallstone formation after gastrectomy in gastric cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Gastric Cancer | Phase 4 | Status: COMPLETED